BIOA Prakiraan wutah bathi kanggo taun ngarep bioagelabs.com
BioAge Labs, Inc. (BIOA) researches aging mechanisms to develop highly scalable drugs with low production costs. Shifting analyst expectations for n+1 EPS growth visualize market sentiment, where 3.00 expresses the latest metric level. Molecule synthesis production is outsourced to third-party US bio-factories to ensure research stability. The company's strategy is based on synergy with industry leaders to expand its portfolio of anti-obesity drugs.
BIOA (BioAge Labs): rincian analitis lan laporan miturut indikator
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi pasar:
- indikator kapitalisasi buku:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal BioAge Labs, Inc.|BIOA - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas BioAge Labs, Inc|BIOA - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku BioAge Labs Inc.|BIOA - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan BioAge Labs, Inc.|Rasio cepet bioagelabs.com
- data bathi resik lan rasio valuasi:
BIOA - Asil keuangan resik|Bathi sing dikarepake BioAge Labs, Inc.|BIOA - Kapitalisasi marang bathi|Pangali Forward P/E bioagelabs.com|BIOA - Pangali PEG|Pangali EV/EBITDA BioAge Labs|BIOA - Bathi operasional sadurunge potongan amortisasi|Bathi resik saben saham (EPS TTM) BioAge Labs, Inc.|BIOA - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan bioagelabs.com|BIOA - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BioAge Labs, Inc.
- data total pendapatan lan volume dodolan:
Analisis wiwitan perusahaan:BIOA, bioagelabs.com
This metric serves as a baseline filter for assessing future return on equity. It measures the average expert expectation for the year-over-year change in earnings per share. By analyzing the growth benchmark for earnings per share for the coming year, an investor identifies the gap between market expectations and reality. For BioAge Labs, Inc. (BIOA), this forecast depends critically on regulatory risks and the stability of global raw material supply chains.
Analisis perusahaan pesaing
ASND (Ascendis) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Madrigal Pharmaceuticals|Prakiraan wutah bathi kanggo taun ngarep CORT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep RYTM (Rhythm Pharma)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep akerotx.com AKRO|Metsera Therapeutics (MTSR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|MLTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|CRNX: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NAMS: Prakiraan wutah bathi kanggo taun ngarep|SLNO - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Amicus Corp|89bio Pharma (ETNB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep agios.com (AGIO)|Prakiraan wutah bathi saben saham kanggo taun ngarep structuretx.com GPCR|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MiMedx Group Inc MDXG|Dinamika bathi saben saham sing diarepake ing taun ngarep RZLT|lexpharma.com - Prakiraan wutah bathi kanggo taun ngarep|MBX (MBX Biosciences Inc) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|ALT: Prakiraan wutah bathi kanggo taun ngarep|Aardvark Therapeutics Inc - Dinamika bathi saben saham sing diarepake ing taun ngarep|SGMT (Sagimet Biosciences, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Biomea Fusion (BMEA)|Prakiraan wutah bathi kanggo taun ngarep QNCX|Proyeksi tambahing bathi saben saham ing taun ngarep GUTS|Prakiraan wutah bathi kanggo taun ngarep VTVT (vTv Therapeutics Inc.)|Dinamika bathi saben saham sing diarepake ing taun ngarep ATPC|Pluristem Therapeutics - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep synlogictx.com SYBX|LPCN: Prakiraan wutah bathi kanggo taun ngarep|Matinas BioPharma Holdings, Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|SPRB (Spruce Biosciences Inc.) - Prakiraan wutah bathi kanggo taun ngarep|galecto.com (GLTO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Carmell Therapeutics (CTCX)|LUMO (Lumos Pharma Inc) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep organovo.com ONVO|Radius Health (RDUS) - Prakiraan wutah bathi resik saben saham ing taun ngarep
